Stigma and Quality of life in Parkinson’s disease patients on different treatment regimens
Objective: To assess self reported quality of life (QOL) in patients with Parkinson’s disease (PD) under different treatment options and to evaluate the emotional burden…Effects of levodopa on LTP-like plasticity induced by quadripulse magnetic stimulation in Parkinson’s disease
Objective: To study LTP-like effect induced by QPS on primary motor cortex of PD patients in “on” or “off” medication state and reveal the relationship…An unusual cause of rhabdomyolysis in the patients with Parkinson’s disease: A report of two cases
Objective: To describe unusual cause of rhabdomyolysis in the two patients with Parkinson’s disease (PD). Background: Levodopa-induced dyskinesia (LID) is usually seen in advanced stage…Long-term levodopa-carbidopa intestinal infusion in Parkinson’s disease: survival and mortality
Objective: We sought to analyze the mortality and the causes of death of 105 patients with Parkinson disease (PD) treated with levodopa-carbidopa intestinal gel (LCIG)…Polyneuropathy in patients with continuous levodopa/carbidopa intestinal gel (LCIG) infusion
Objective: To assess frequency of polyneuropathy in patients with LCIG and the usefulness of routine nerve conduction studies follow-up Background: Continuous levodopa infusion is an…Caregiver support and its association with advanced Parkinson’s disease and clinical outcomes
Objective: To assess characteristics of advanced Parkinson’s disease (APD) patients with ongoing device-aided treatment stratified by caregiver support. Background: Observe-PD is a multicountry, cross-sectional observational…Pharmacokinetics of Accordion Pill™ Carbidopa/Levodopa Following Multiple Doses in Patients With Parkinson’s Disease
Objective: To perform a pharmacokinetic (PK) assessment of a novel carbidopa/levodopa drug delivery system (Accordion Pill™; AP-CD/LD) and to determine if multiple doses of AP-CD/LD…Influence of controlled-release levodopa on quality of sleep and nocturnal movements
Objective: To evaluate the effects of controlled-released (CR) levodopa on quality of sleep and nocturnal movements as assessed with mobile health technology in patients with…Availability of Parkinson’s disease medicines in Ghana: a national survey
Objective: To determine the affordability, availability, geographic distribution and financing options of Parkinson’s disease (PD) medication in Ghana. Background: In sub-Saharan Africa, patients with PD…BouNDless: An active-controlled randomized, double-blind double-dummy study of continuous ND0612 infusion in patients with fluctuating Parkinson’s disease
Objective: Determine the efficacy, safety, and tolerability of continuous subcutaneous ND0612 infusion in comparison to oral Carbidopa/Levodopa (CD/LD) in patients with Parkinson’s disease (PD) experiencing…
- « Previous Page
- 1
- …
- 33
- 34
- 35
- 36
- 37
- …
- 57
- Next Page »